The value of hepatic resection in metastasic renal cancer in the Era of Tyrosinkinase Inhibitor Therapy

BACKGROUND: The value of liver-directed therapy (LDT) in patients with metastasic renal cell carcinoma (MRCC) is still an active field of research, particularly in the era of tyrosinkinase inhibitor (TKI) therapy. METHODS: The records of 35 patients with MRCC undergoing LDT of metastasic liver lesio...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:BMC Surg
Autores principales: Hau, Hans Michael, Thalmann, Florian, Lübbert, Christoph, Morgul, Mehmet Haluk, Schmelzle, Moritz, Atanasov, Georgi, Benzing, Christian, Lange, Undine, Ascherl, Rudolf, Ganzer, Roman, Uhlmann, Dirk, Tautenhahn, Hans-Michael, Wiltberger, Georg, Bartels, Michael
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4957271/
https://ncbi.nlm.nih.gov/pubmed/27444582
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12893-016-0163-0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares